Beijing Strong Biotechnologies,Inc. (SHE:300406)
China flag China · Delayed Price · Currency is CNY
12.31
-0.37 (-2.92%)
Apr 28, 2026, 3:04 PM CST

SHE:300406 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Equivalents
673.35539.651,043724.04340.72382.52
Short-Term Investments
--88.4152.2325.3310.01
Cash & Short-Term Investments
673.35539.651,131876.24666.05392.53
Cash Growth
-36.58%-52.29%29.08%31.56%69.68%-34.83%
Accounts Receivable
1,0701,0311,1651,1981,039948.99
Other Receivables
10.6910.2214.477.984.84103.76
Receivables
1,0811,0421,1791,2061,1241,053
Inventory
189.03187.11220.68229.74219.65252.01
Other Current Assets
405.16431.2850.2722.556.9343.65
Total Current Assets
2,3492,2002,5812,3342,0671,741
Property, Plant & Equipment
531.79546581.77555.24438.93366.19
Long-Term Investments
89.6990.74597.61472.73300.74397.77
Goodwill
1,4981,4981,6731,6731,6731,673
Other Intangible Assets
53.1156.0657.0860.4965.8373.84
Long-Term Accounts Receivable
--6.1126.314.8233.12
Long-Term Deferred Tax Assets
43.4643.4348.3745.8537.7331.33
Long-Term Deferred Charges
1.421.531.922.853.323.33
Other Long-Term Assets
617.46617.1928.565.4812.450.66
Total Assets
5,1835,0525,5755,1764,6134,320
Accounts Payable
45.4951.9369.2981.7137.6547.14
Accrued Expenses
13.6841.3282.82108.2199.7107.35
Short-Term Debt
0.080.060.11-81.04163.46
Current Portion of Long-Term Debt
13.879.6837.912.831.74192.99
Current Portion of Leases
--1.461.132.020.73
Current Income Taxes Payable
48.1439.0733.4823.1420.5326.16
Current Unearned Revenue
22.7911.2920.2718.9520.5719.43
Other Current Liabilities
48.8217.9532.7961.1334.6950.35
Total Current Liabilities
192.87171.32278.13297.12297.94607.6
Long-Term Debt
1,0721,0641,1241,1271,017766.4
Long-Term Leases
3.974.085.254.911.040.91
Long-Term Unearned Revenue
22.9524.0528.1316.9718.6520.45
Long-Term Deferred Tax Liabilities
5.926.237.138.459.8210.98
Total Liabilities
1,2981,2701,4421,4541,3441,406
Common Stock
586.31586.31588.33588.45588.84588.98
Additional Paid-In Capital
345.4347.38382.47399.95392.12487.69
Retained Earnings
2,8692,7633,0842,6682,2031,873
Treasury Stock
-57.84-57.84-93.63-109.59-93.07-74.8
Comprehensive Income & Other
148.57148.83177.52177.3179.98-0.54
Total Common Equity
3,8913,7884,1383,7253,2712,874
Minority Interest
-5.9-5.16-5.57-3.04-2.4439
Shareholders' Equity
3,8853,7834,1333,7223,2692,913
Total Liabilities & Equity
5,1835,0525,5755,1764,6134,320
Total Debt
1,0901,0781,1681,1361,1021,124
Net Cash (Debt)
-416.63-538.07-37.2-259.39-436.45-731.96
Net Cash Per Share
-0.70-0.91-0.06-0.44-0.71-1.25
Filing Date Shares Outstanding
586.71596.51537.79559.57568.93588.98
Total Common Shares Outstanding
586.71596.51537.79559.57568.93588.98
Working Capital
2,1562,0282,3032,0371,7691,133
Book Value Per Share
6.636.357.706.665.754.88
Tangible Book Value
2,3412,2342,4091,9921,5331,128
Tangible Book Value Per Share
3.993.754.483.562.691.92
Buildings
--518.07288.33288.33280.47
Machinery
--297.51262.57249.98244.43
Construction In Progress
---211.0374.820.08
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.